Related Experiment Videos
Rapidly progressive hepatitis C in a patient with common variable immunodeficiency
R Sumazaki1, T Matsubara, T Aoki
1Department of Paediatrics, University of Tsukuba, Ibaraki, Japan.
European Journal of Pediatrics
|July 1, 1996
Summary
Hepatitis C can progress rapidly in children, even leading to fatal liver disease, contrary to common belief. Immune deficiency conditions may accelerate hepatitis C progression in pediatric patients.
Area of Science:
- Hepatology
- Virology
- Immunology
Background:
- Common variable immunodeficiency (CVID) is a primary immunodeficiency disorder.
- Hepatitis C virus (HCV) infection is a significant global health concern.
- Paediatric hepatitis C is often considered to have a benign short-term prognosis.
Observation:
- A 15-year-old female with CVID contracted HCV infection.
- She presented with high levels of HCV-RNA, indicating active viral replication.
- No other hepatotoxic factors were identified besides HCV infection.
Findings:
- The patient developed liver cirrhosis and hepatic failure within 5 years of HCV diagnosis.
- Liver biopsies and autopsy confirmed rapid histopathological changes over 4 years.
- This case demonstrates rapid progression of liver disease in a pediatric patient with HCV and CVID.
Implications:
- Rapidly progressive liver disease can occur in paediatric HCV infection, challenging the notion of a benign prognosis.
- Immune deficiency may be a risk factor for accelerated HCV progression in children.
- Antiviral therapy is warranted for high-risk pediatric groups with HCV infection.